| Travel-related illnesses and injury n = 17 (53%) |
|
|
| Infectious disease (COVID-19) |
1 |
3% |
| Infectious disease (pre-travel consultation) |
3 |
9% |
| Infectious disease (Vaccine) |
3 |
9% |
| Infectious disease (KAP) |
3 |
9% |
| Jet lag |
3 |
9% |
| Travel-related illnesses and injury (except for infectious disease) |
4 |
13% |
| Impact of business travel on employees’ daily life and well-being n = 12 (38%) |
|
|
| Adiposity |
1 |
3% |
| Well-being |
4 |
13% |
| Well-being/leadership |
1 |
3% |
| Work style |
2 |
9% |
| Work style/ Well-being |
3 |
9% |
| Employer healthcare for business travelers n = 3 (9%) |
|
|
| Total |
31 |
100% |
